A cosmetic accounting benefit of such a deal for PFE would be the ability to book Eliquis product sales. Currently, BMY books 100% of Eliquis sales, while PFE reports its share of Eliquis net profits as "collaborative revenue."
Interesting....ex Pfizer Satish Chandran worked with BMS? as he led the Center of Excellence at NDSU and ties to CSM in Fargo ND ....
....not sure what happened there but something big if emails went missing at NDSU and the Peregrine lawsuit vs CSM has been closed and sealed by the judge....from the public
News 
Market Data 
Discover 
